Phytomedicine Plus (May 2023)
In-depth analysis of the chemical composition, pharmacological effects, pharmacokinetics, and patent history of mangiferin
Abstract
Introduction: Mangiferin (2-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one) is extracted from different part of plants such seed, peel, and kernels of mango. Methods: In many studies mangiferin was studied for its antidiabetic, antioxidant, antibacterial, anticancer, immunomodulatory, and hypocholesterolaemia activity. It mainly works by altering the transcription process which further led to inhibition of peroxisome proliferator activated receptor. By preventing the expression of tumor necrosis factor, inducible nitric oxide synthase potential, proliferation, and apoptosis, mangiferin defends against a variety of human malignancies, such as breast, lung, brain, and colon tumours. It could defend against physiological hazards by preventing lipid peroxidation. Results: The present review focuses on an updated account of investigation related to mangiferin's chemo preventive activity, apoptosis induction in cancer cells, potential antioxidative activities, and patent mapping of additional therapeutic aspects. This review also highlights the different molecular targets of Mangiferin, as well as its potential as a polyphenol. Conclusion: From the finding of this review, it was concluded that Mangiferin has versatile pharmacological properties could serves as economic, safe and potential ailment in the treatment of diseases as well as dietary supplements.
